Log In
BCIQ
Print this Print this
 

UPA UF

  Manage Alerts
Collapse Summary General Information
Company HRA Pharma S.A.
DescriptionBased on ulipristal acetate, a selective progesterone receptor modulator
Molecular Target Progesterone receptor (PGR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationUterine fibroids
Indication DetailsTreat uterine fibroids
Regulatory Designation EU - Standard Review (Treat uterine fibroids)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today